Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sponsors Should Hang Tight On “New Paradigm” Switch – CDER’s Leonard-Segal

This article was originally published in The Tan Sheet

Executive Summary

The director of FDA’s Division of Nonprescription Clinical Evaluation advises firms to wait to submit Rx-to-OTC switch applications until the regulations are revised to allow for expanded conditions of safe nonprescription use.

Advertisement

Related Content

Former Division Of Nonprescription Clinical Evaluation Head Leonard-Segal Talks About OTC Switches Past, Present And Future
Former Division Of Nonprescription Clinical Evaluation Head Leonard-Segal Talks About OTC Switches Past, Present And Future
Interview: Leonard-Segal On OTC Switch Past, Present and Future
Interview: Leonard-Segal On OTC Switch Past, Present and Future
FDA Sketches NSURE Novel Switch Initiative In 2012
FDA Sketches NSURE Novel Switch Initiative In 2012
Promise Of A New Day For Rx-To-OTC Switch Ruled 2012 In “The Tan Sheet”
Promise Of A New Day For Rx-To-OTC Switch Ruled 2012 In “The Tan Sheet”
Experts Support Statin, Triptan, Sleep Aid Switches In New Paradigm

Topics

Advertisement
UsernamePublicRestriction

Register

PS105757

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel